Concourse Financial Group Securities, Inc. Cue Biopharma, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding CUE
# of Institutions
49Shares Held
17.5MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.57 Million1.47% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.23 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$2.04 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$507,0130.0% of portfolio
-
Geode Capital Management, LLC Boston, MA692KShares$463,7550.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $23.7M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...